168 related articles for article (PubMed ID: 33931673)
1. Effects of stent generation on clinical outcomes after acute myocardial infarction compared between prediabetes and diabetes patients.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Sci Rep; 2021 Apr; 11(1):9364. PubMed ID: 33931673
[TBL] [Abstract][Full Text] [Related]
2. Comparison of First- and Second-Generation Drug-Eluting Stents in Patients with Acute Myocardial Infarction and Prediabetes Based on the Hemoglobin A1c Level.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
J Interv Cardiol; 2020; 2020():1710439. PubMed ID: 32733169
[TBL] [Abstract][Full Text] [Related]
3. Two-Year Clinical Outcomes Between Prediabetic and Diabetic Patients With STEMI and Multivessel Disease Who Underwent Successful PCI Using Drug-Eluting Stents.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Angiology; 2021 Jan; 72(1):50-61. PubMed ID: 32806925
[TBL] [Abstract][Full Text] [Related]
4. Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Catheter Cardiovasc Interv; 2020 Feb; 95(2):E40-E55. PubMed ID: 31423723
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the impact of current smoking on 2-year major clinical outcomes of first- and second-generation drug-eluting stents in acute myocardial infarction: Data from the Korea Acute Myocardial Infarction Registry.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Medicine (Baltimore); 2019 Mar; 98(10):e14797. PubMed ID: 30855497
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Durable-Polymer- and Biodegradable-Polymer-Based Newer-Generation Drug-Eluting Stents in Patients with Acute Myocardial Infarction and Prediabetes After Successful Percutaneous Coronary Intervention.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Int Heart J; 2020 Jul; 61(4):673-684. PubMed ID: 32684595
[TBL] [Abstract][Full Text] [Related]
7. Prediabetes versus type 2 diabetes mellitus based on pre-percutaneous coronary intervention thrombolysis in myocardial infarction flow grade in patients with ST-segment elevation myocardial infarction after successful newer-generation drug-eluting stent implantation.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Diab Vasc Dis Res; 2021; 18(1):1479164121991505. PubMed ID: 33535819
[TBL] [Abstract][Full Text] [Related]
8. Effects of prediabetes on long-term clinical outcomes of patients with acute myocardial infarction who underwent PCI using new-generation drug-eluting stents.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Diabetes Res Clin Pract; 2020 Feb; 160():107994. PubMed ID: 31881240
[TBL] [Abstract][Full Text] [Related]
9. Comparative effect of statin intensity between prediabetes and type 2 diabetes mellitus after implanting newer-generation drug-eluting stents in Korean acute myocardial infarction patients: a retrospective observational study.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
BMC Cardiovasc Disord; 2021 Aug; 21(1):386. PubMed ID: 34372778
[TBL] [Abstract][Full Text] [Related]
10. Outcomes between prediabetes and type 2 diabetes mellitus in older adults with acute myocardial infarction in the era of newer-generation drug-eluting stents: a retrospective observational study.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Park SH; Kim BG; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
BMC Geriatr; 2021 Nov; 21(1):653. PubMed ID: 34798819
[TBL] [Abstract][Full Text] [Related]
11. Two-Year Safety and Efficacy of Biodegradable Polymer Drug-Eluting Stent Versus Second-Generation Durable Polymer Drug-Eluting Stent in Patients With Acute Myocardial Infarction: Data from the Korea Acute Myocardial Infarction Registry (KAMIR).
Hur SH; Kim IC; Won KB; Cho YK; Yoon HJ; Nam CW; Kim KB; Kim MS; Park J; Rha SW; Chae SC; Kim YJ; Kim CJ; Cho MC; Jeong MH; Ahn YK; Kim HS; Ahn TH; Seung KB; Jang Y; Yoon JH; Seong IW; Hong TJ; Bae JH; Park SJ;
Clin Cardiol; 2016 May; 39(5):276-84. PubMed ID: 27028303
[TBL] [Abstract][Full Text] [Related]
12. Comparison of First- and Second-Generation Drug-Eluting Stents in Patients with ST-Segment Elevation Myocardial Infarction Based on Pre-Percutaneous Coronary Intervention Thrombolysis in Myocardial Infarction Flow Grade.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33478003
[TBL] [Abstract][Full Text] [Related]
13. Effect of statin treatment in patients with acute myocardial infarction with prediabetes and type 2 diabetes mellitus: A retrospective observational registry study.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Medicine (Baltimore); 2021 Feb; 100(6):e24733. PubMed ID: 33578620
[TBL] [Abstract][Full Text] [Related]
14. Outcomes in prediabetes vs. diabetes in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous intervention.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Coron Artery Dis; 2021 May; 32(3):211-223. PubMed ID: 33060525
[TBL] [Abstract][Full Text] [Related]
15. Prediabetes versus type 2 diabetes in patients with acute myocardial infarction and current smoking.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Am J Med Sci; 2022 Nov; 364(5):612-623. PubMed ID: 35595078
[TBL] [Abstract][Full Text] [Related]
16. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials.
Sabaté M; Räber L; Heg D; Brugaletta S; Kelbaek H; Cequier A; Ostojic M; Iñiguez A; Tüller D; Serra A; Baumbach A; von Birgelen C; Hernandez-Antolin R; Roffi M; Mainar V; Valgimigli M; Serruys PW; Jüni P; Windecker S
JACC Cardiovasc Interv; 2014 Jan; 7(1):55-63. PubMed ID: 24332419
[TBL] [Abstract][Full Text] [Related]
17. Five-year major clinical outcomes between first-generation and second-generation drug-eluting stents in acute myocardial infarction patients underwent percutaneous coronary intervention.
Kim YH; Her AY; Rha SW; Choi BG; Choi SY; Byun JK; Baek JY; Choi WG; Kang TS; Ahn JH; Park SH; Mashaly A; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ
J Geriatr Cardiol; 2018 Aug; 15(8):523-533. PubMed ID: 30344532
[TBL] [Abstract][Full Text] [Related]
18. Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials.
Ploumen EH; Pinxterhuis TH; Zocca P; Roguin A; Anthonio RL; Schotborgh CE; Benit E; Aminian A; Danse PW; Doggen CJM; von Birgelen C; Kok MM
Cardiovasc Diabetol; 2021 Oct; 20(1):217. PubMed ID: 34717627
[TBL] [Abstract][Full Text] [Related]
19. Improved clinical outcome with biodegradable polymer drug-eluting stents compared to durable polymer drug-eluting stents for primary percutaneous coronary intervention.
Andriyati R; Firman D; Kurniawati Y; Alkatiri AA; Pranata R; Muliawan HS; Rossimarina V; Soerianata S
Postgrad Med J; 2021 Oct; 97(1152):638-643. PubMed ID: 32796116
[TBL] [Abstract][Full Text] [Related]
20. Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
Giustino G; Harari R; Baber U; Sartori S; Stone GW; Leon MB; Windecker S; Serruys PW; Kastrati A; Von Birgelen C; Kimura T; Stefanini GG; Dangas GD; Wijns W; Steg PG; Morice MC; Camenzind E; Weisz G; Smits PC; Sorrentino S; Sharma M; Farhan S; Faggioni M; Kandzari D; Galatius S; Jeger RV; Valgimigli M; Itchhaporia D; Mehta L; Kim HS; Chieffo A; Mehran R
JAMA Cardiol; 2017 Aug; 2(8):855-862. PubMed ID: 28658478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
